Earnings · China A-shares
Xiangxue Pharmaceutical Co., Ltd. Class A (300147) earnings
Xiangxue Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -15.44% year on year, +30.10% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -6.80% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -15.44%
- Excl. one-offs YoY
- +30.10%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +9.69% | — |
| 3 days | -6.80% | — |
| 7 days | +0.00% | — |
| 14 days | +24.12% | — |
Report history
Over the last 8 reports, net profit grew year on year in 0 of them. The stock rose in the 3 trading days after 2 of 6 reports (average +1.10%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | -¥417.80M | -15.44% | +30.10% | -7.14% | -0.63 | — | -6.80% | — | — |
| 2026 interim report | 2026-08-26 | -¥268.82M | -14.94% | +22.48% | -14.09% | -0.41 | — | -1.49% | -21.82% | -14.83% |
| 2026 Q1 report | 2026-04-29 | -¥111.44M | -27.02% | +14.03% | -15.88% | -0.17 | — | +9.88% | +0.74% | -0.20% |
| 2025 annual report | 2026-04-29 | -¥1.39B | -62.15% | -30.37% | -14.16% | -2.11 | — | +9.88% | +0.74% | -0.20% |
| 2025 Q3 report | 2025-10-28 | -¥361.90M | -66.16% | -51.66% | -25.28% | -0.55 | -41.00% | -7.12% | -7.32% | -3.94% |
| 2025 interim report | 2025-08-28 | -¥233.87M | -72.96% | -91.43% | -25.40% | -0.35 | -24.93% | -0.35% | -6.00% | -11.50% |
| 2025 Q1 report | 2025-04-29 | -¥87.73M | -146.03% | — | -25.99% | -0.13 | -8.68% | +12.50% | +52.54% | +49.96% |
| 2024 annual report | 2025-04-29 | -¥858.56M | -120.73% | — | -19.16% | -1.30 | -57.41% | +12.50% | +52.54% | +49.96% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.